newsfilter
← Latest News
GlobeNewswire·

Icosavax to Participate in the Jefferies Healthcare Conference

SEATTLE, June 01, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle platform technology to develop combination vaccines against infectious diseases, with an initial focus on